Darren Bridgewater

976 total citations
30 papers, 674 citations indexed

About

Darren Bridgewater is a scholar working on Molecular Biology, Urology and Nephrology. According to data from OpenAlex, Darren Bridgewater has authored 30 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Urology and 9 papers in Nephrology. Recurrent topics in Darren Bridgewater's work include Renal and related cancers (22 papers), Urological Disorders and Treatments (10 papers) and Renal cell carcinoma treatment (7 papers). Darren Bridgewater is often cited by papers focused on Renal and related cancers (22 papers), Urological Disorders and Treatments (10 papers) and Renal cell carcinoma treatment (7 papers). Darren Bridgewater collaborates with scholars based in Canada, United States and Finland. Darren Bridgewater's co-authors include Norman D. Rosenblum, Jason E. Cain, Felix Boivin, Douglas G. Matsell, Kirsi Sainio, Brian Cox, Sanjay Sarin, Satu Kuure, Valeria Di Giovanni and Agnes Lau and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Kidney International.

In The Last Decade

Darren Bridgewater

28 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darren Bridgewater Canada 14 463 177 141 130 104 30 674
Lisa Williams‐Simons United States 9 436 0.9× 105 0.6× 190 1.3× 33 0.3× 122 1.2× 9 551
Susan M. Kiefer United States 10 385 0.8× 118 0.7× 129 0.9× 87 0.7× 64 0.6× 10 560
Michele Karolak United States 11 429 0.9× 194 1.1× 84 0.6× 37 0.3× 55 0.5× 23 537
Jolanta E. Pitera United Kingdom 9 261 0.6× 52 0.3× 173 1.2× 81 0.6× 55 0.5× 14 503
Alina C. Hilger Germany 15 346 0.7× 121 0.7× 222 1.6× 42 0.3× 189 1.8× 36 625
Mita M. Shah United States 10 401 0.9× 101 0.6× 104 0.7× 16 0.1× 103 1.0× 22 519
Meaghan Russell United States 10 303 0.7× 242 1.4× 112 0.8× 41 0.3× 56 0.5× 18 688
Irma S Lantinga‐van Leeuwen Netherlands 14 716 1.5× 151 0.9× 761 5.4× 65 0.5× 65 0.6× 17 970
J. Garcı́a Rodrı́guez Spain 9 161 0.3× 96 0.5× 163 1.2× 28 0.2× 60 0.6× 54 431

Countries citing papers authored by Darren Bridgewater

Since Specialization
Citations

This map shows the geographic impact of Darren Bridgewater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren Bridgewater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren Bridgewater more than expected).

Fields of papers citing papers by Darren Bridgewater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren Bridgewater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren Bridgewater. The network helps show where Darren Bridgewater may publish in the future.

Co-authorship network of co-authors of Darren Bridgewater

This figure shows the co-authorship network connecting the top 25 collaborators of Darren Bridgewater. A scholar is included among the top collaborators of Darren Bridgewater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren Bridgewater. Darren Bridgewater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coffman, E. J., Heather L. Chandler, Zbyněk Kozmík, et al.. (2025). Shroom3 facilitates optic fissure closure via tissue alignment and reestablishment of apical-basal polarity during epithelial fusion. Developmental Biology. 522. 91–105. 1 indexed citations
2.
Carleton, Jane, et al.. (2025). Understanding the role of Shroom3 in the developing mouse myocardium. PLoS ONE. 20(9). e0331583–e0331583.
3.
Mäkelä, O., et al.. (2025). Epithelial cell shape changes contribute to regulation of ureteric bud branching morphogenesis. FEBS Journal. 292(23). 6253–6282.
4.
Li, Anna, et al.. (2023). β‐Catenin in the kidney stroma modulates pathways and genes to regulate kidney development. Developmental Dynamics. 252(9). 1224–1239. 1 indexed citations
5.
Paul, A., et al.. (2023). The Good and the Bad of SHROOM3 in Kidney Development and Disease: A Narrative Review. Canadian Journal of Kidney Health and Disease. 10. 1035167238–1035167238. 2 indexed citations
6.
Platko, Khrystyna, Paul Lebeau, Šárka Lhoták, et al.. (2020). TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells. Arteriosclerosis Thrombosis and Vascular Biology. 40(7). 1664–1679. 12 indexed citations
7.
Morikawa, Lily, et al.. (2020). Quercetin treatment reduces the severity of renal dysplasia in a beta-catenin dependent manner. PLoS ONE. 15(6). e0234375–e0234375. 4 indexed citations
8.
Ayaub, Ehab, Philipp Kolb, Zahraa Mohammed‐Ali, et al.. (2016). GRP78 and CHOP modulate macrophage apoptosis and the development of bleomycin‐induced pulmonary fibrosis. The Journal of Pathology. 239(4). 411–425. 92 indexed citations
9.
Boivin, Felix, et al.. (2015). The Good and Bad of β-Catenin in Kidney Development and Renal Dysplasia. Frontiers in Cell and Developmental Biology. 3. 81–81. 9 indexed citations
10.
Bridgewater, Darren. (2015). Life as a New Investigator. Canadian Journal of Kidney Health and Disease. 2. 47–47. 1 indexed citations
11.
Sarin, Sanjay, et al.. (2014). β-Catenin Overexpression in the Metanephric Mesenchyme Leads to Renal Dysplasia Genesis via Cell-Autonomous and Non–Cell-Autonomous Mechanisms. American Journal Of Pathology. 184(5). 1395–1410. 20 indexed citations
12.
Sarin, Sanjay, Felix Boivin, Iakovina Alexopoulou, et al.. (2014). Insights into the Renal Pathogenesis in Schimke Immuno-Osseous Dysplasia. Journal of Histochemistry & Cytochemistry. 63(1). 32–44. 14 indexed citations
13.
Bridgewater, Darren, Valeria Di Giovanni, Jason E. Cain, et al.. (2011). β-Catenin Causes Renal Dysplasia via Upregulation of Tgfβ2 and Dkk1. Journal of the American Society of Nephrology. 22(4). 718–731. 29 indexed citations
14.
Bridgewater, Darren, Brian Cox, Jason E. Cain, et al.. (2008). Canonical WNT/β-catenin signaling is required for ureteric branching. Developmental Biology. 317(1). 83–94. 112 indexed citations
15.
Bridgewater, Darren & Norman D. Rosenblum. (2008). Stimulatory and inhibitory signaling molecules that regulate renal branching morphogenesis. Pediatric Nephrology. 24(9). 1611–1619. 24 indexed citations
16.
Hartwig, Sunny, Darren Bridgewater, Valeria Di Giovanni, et al.. (2008). BMP Receptor ALK3 Controls Collecting System Development. Journal of the American Society of Nephrology. 19(1). 117–124. 46 indexed citations
17.
Bridgewater, Darren, et al.. (2007). The role of the type I insulin-like growth factor receptor (IGF-IR) in glomerular integrity. Growth Hormone & IGF Research. 18(1). 26–37. 23 indexed citations
18.
Bridgewater, Darren, et al.. (2005). Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway. Kidney International. 67(4). 1308–1314. 65 indexed citations
19.
Bridgewater, Darren & Douglas G. Matsell. (2003). Insulin-like growth factor binding protein-2 modulates podocyte mitogenesis. Pediatric Nephrology. 18(11). 1109–1115. 12 indexed citations
20.
Bridgewater, Darren, Amy Mok, & Douglas G. Matsell. (2000). Expression of complement regulatory proteins in the developing human kidney. Pediatric Nephrology. 15(1-2). 36–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026